NDC codes

FDA NDC Directory
Product NDC (as listed)42747-327Labeler and product segments. Claims need a package NDC.
Product NDC at billing width42747-0327Add the package segment from the table below.
Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC11-digit (billing)PackageCopy
42747-327-304274703273030 TABLET in 1 BOTTLE (42747-327-30)Marketed from Jun 30, 1997
42747-327-72427470327727 TABLET in 1 BLISTER PACK (42747-327-72)Marketed from Jun 30, 1997

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary)
Fareston
Generic name (nonproprietary)
toremifene citrate
Active ingredients
Toremifene citrate — 60 mg/1
Dosage form
Tablet
Route
Oral
Labeler
Kyowa Kirin, Inc.NDC labeler code 42747
Product type
Prescription drug
Marketing category
NDA — New Drug ApplicationApplication NDA 020497
Marketing start
Listing expires
Other FDA classes
Selective Estrogen Receptor Modulators (Mechanism)
Identifiers
Product ID 42747-327_11857fbe-6c5e-485e-b5d4-7f091a331928SPL ID 11857fbe-6c5e-485e-b5d4-7f091a331928SPL set ID 2cab8dd1-3a10-48e6-86ce-0e5275ed49e5RxCUI 152880, 313428UNII 2498Y783QT
Pharmacologic class
Estrogen Agonist/Antagonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N442747032730 followed by a unit qualifier and the quantity

Package 42747-0327-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective . This label includes a boxed warning.

Indications (excerpt from the label)

FARESTON® is an estrogen agonist/antagonist indicated for the treatment of metastatic breast cancer in postmenopausal women with estrogen-receptor positive or unknown tumors. FARESTON® is an estrogen agonist/antagonist indicated for the treatment of metastatic breast cancer in postmenopausal women with estrogen-receptor positive or unknown tumors. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 42747-327

What is NDC 42747-327?
42747-327 is the product NDC for Fareston (toremifene citrate), Toremifene citrate 60 mg/1 tablet, listed with the FDA by Kyowa Kirin, Inc.. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?
Fareston (Toremifene citrate).
What is the active ingredient?
Toremifene citrate.
Who is the labeler?
Kyowa Kirin, Inc., NDC labeler code 42747. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Fareston?
None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?
Not in Med-Code's curated HCPCS directory. See Billing references above.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free Med-Code account to keep looking up NDCs, J-codes and drugs.

Create a free accountLog in